Logo-ijhpm
Commentary

1. Health Services Research Spending and Healthcare System Impact Comment on “Public Spending on Health Service and Policy Research in Canada, the United Kingdom, and the United States: A Modest Proposal”
Stirling Bryan
Int J Health Policy Manag. 2018;7(3): 278-281. doi: 10.15171/ijhpm.2017.92
PMCID: PMC5890075     PMID: 29524959    
Article
PDF
XML
Cited By:
Commentary

2. It’s All About the IKT Approach: Three Perspectives on an Embedded Research Fellowship Comment on “CIHR Health System Impact Fellows: Reflections on ‘Driving Change’ Within the Health System”
Christine E. Cassidy* ORCID, Stacy Burgess, Ian D. Graham ORCID
Int J Health Policy Manag. 2019;8(7): 455-458. doi: 10.15171/ijhpm.2019.31
PMCID: PMC6706976     PMID: 31441283    
Article
PDF
XML
Cited By:
Commentary

3. The Health System Impact Fellowship: Perspectives From the Program Leads Comment on “CIHR Health System Impact Fellows: Reflections on ‘Driving Change’ Within the Health System”
Meghan McMahon* ORCID, Robyn Tamblyn ORCID
Int J Health Policy Manag. 2019;8(10): 623-626. doi: 10.15171/ijhpm.2019.59
PMCID: PMC6819624     PMID: 31657192    
Article
PDF
XML
Cited By:
Editorial

4. Universal Pharmacare in Canada: A Prescription for Equity in Healthcare
Mohammad Hajizadeh* ORCID, Sterling Edmonds
Int J Health Policy Manag. 2020;9(3): 91-95. doi: 10.15171/ijhpm.2019.93
PMCID: PMC7093046     PMID: 32202091    
Article
PDF
XML
Cited By:
Perspective

5. Team-Based Integrated Knowledge Translation for Enhancing Quality of Life in Long-term Care Settings: A Multi-method, Multi-sectoral Research Design
Janice Keefe ORCID, Mary Jean Hande*, Katie Aubrecht, Tamara Daly, Denise Cloutier, Deanne Taylor, Matthias Hoben, Kelli Stajduhar, Heather Cook, Ivy Lynn Bourgeault, Leah MacDonald, Carole A. Estabrooks
Int J Health Policy Manag. 2020;9(4): 138-142. doi: 10.15171/ijhpm.2019.123
PMCID: PMC7182150     PMID: 32331493    
Article
PDF
XML
Cited By:
Short Communication

6. How to Work Collaboratively Within the Health System: Workshop Summary and Facilitator Reflection
Christine E. Cassidy* ORCID, Sarah Bowen ORCID, Guillaume Fontaine ORCID, Élizabeth Côté-Boileau ORCID, Ingrid Botting ORCID
Int J Health Policy Manag. 2020;9(6): 233-239. doi: 10.15171/ijhpm.2019.131
PMCID: PMC7382904     PMID: 32613791    
Article
PDF
Suppl 1
XML
Cited By:
Commentary

7. It’s Time to Finally Kill the Zombies Comment on “Universal Pharmacare in Canada”
Joel Lexchin* ORCID
Int J Health Policy Manag. 2020;9(12): 528-530. doi: 10.15171/ijhpm.2020.03
PMCID: PMC7947650     PMID: 32610770    
Article
PDF
XML
Cited By:
Commentary

8. The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged Comment on “Pharmacare in Canada”
Kristina M. L. Acri née Lybecker* ORCID
Int J Health Policy Manag. 2021;10(3): 152-154. doi: 10.15171/ijhpm.2020.20
PMCID: PMC7947897     PMID: 32610780    
Article
PDF
XML
Cited By:
Commentary

9. Separated at Birth: The Politics of Pharmacare for All in Canada and Medicare for All in the United States Comment on “Universal Pharmacare in Canada”
Carolyn Hughes Tuohy* ORCID
Int J Health Policy Manag. 2021;10(3): 162-164. doi: 10.34172/ijhpm.2020.31
PMCID: PMC7947896     PMID: 32610786    
Article
PDF
XML
Cited By:
Commentary

10. Understanding the Battle for Universal Pharmacare in Canada Comment on “Universal Pharmacare in Canada”
Marc-André Gagnon* ORCID
Int J Health Policy Manag. 2021;10(3): 168-171. doi: 10.34172/ijhpm.2020.40
PMCID: PMC7947898     PMID: 32610789    
Article
PDF
XML
Cited By:
Short Communication

11. Development Time and Patent Extension for Prescription Drugs in Canada: A Cohort Study
Joel Lexchin* ORCID
Int J Health Policy Manag. 2021;10(8): 495-499. doi: 10.34172/ijhpm.2020.100
PMCID: PMC9056197     PMID: 32610816    
Article
PDF
Suppl 1
XML
Cited By:
Original Article

12. Ethical and Social Values for Paediatric Health Technology Assessment and Drug Policy
Avram E. Denburg* ORCID, Mita Giacomini, Wendy Ungar, Julia Abelson ORCID
Int J Health Policy Manag. 2022;11(3): 374-382. doi: 10.34172/ijhpm.2020.144
PMCID: PMC9278467     PMID: 32801223    
Article
PDF
XML
Cited By:
Original Article

13. The Impact of Tiered-Pricing Framework on Generic Entry in Canada
Wei Zhang ORCID, Huiying Sun, Daphne P. Guh, Larry D. Lynd, Aidan Hollis, Paul Grootendorst, Aslam H. Anis* ORCID
Int J Health Policy Manag. 2022;11(6): 768-776. doi: 10.34172/ijhpm.2020.215
PMCID: PMC9309918     PMID: 33233033    
Article
PDF
Suppl 1
Suppl 2
Suppl 3
XML
Cited By:
Original Article

14. How Do Health Systems Address Patient Flow When Services Are Misaligned With Population Needs? A Qualitative Study
Sara Kreindler* ORCID, Zaid Aboud, Stephanie Hastings, Shannon Winters, Keir Johnson, Sara Mallinson, Meaghan Brierley
Int J Health Policy Manag. 2022;11(8): 1362-1372. doi: 10.34172/ijhpm.2021.36
PMCID: PMC9808352     PMID: 33949820    
Article
PDF
XML
Cited By:
Original Article

15. “My Cancer Is Worth Only Fifteen Weeks”? A Critical Analysis of the Lived Experiences of Financial Toxicity and Cancer in Canada
Ambreen Sayani* ORCID, Jessica Dilney ORCID, Janet L. Kuhnke ORCID, Tom McNeil ORCID
Int J Health Policy Manag. 2022;11(9): 1814-1822. doi: 10.34172/ijhpm.2021.83
PMCID: PMC9808211     PMID: 34634872    
Article
PDF
XML
Cited By:
Short Communication

16. Donations Made and Received: A Study of Disclosure Practices of Pharmaceutical Companies and Patient Groups in Canada
Joel Lexchin* ORCID
Int J Health Policy Manag. 2022;11(10): 2046-2053. doi: 10.34172/ijhpm.2021.172
PMCID: PMC9808287     PMID: 35021614    
Article
PDF
Suppl 1
Suppl 2
Suppl 3
XML
Cited By:
Original Article

17. The Maritime SPOR SUPPORT Unit (MSSU) Bridge Process: An Integrated Knowledge Translation Approach to Address Priority Health Issues and Increase Collaborative Research in Nova Scotia, Canada
Julia Kontak* ORCID, Amy Grant ORCID, Elizabeth Jeffers, Leah Boulos ORCID, Juanna Ricketts, Michael Davies, Marina Hamilton, Jill A. Hayden ORCID
Int J Health Policy Manag. 2023;12: 6901 | Published on: 2023 Feb 14. doi: 10.34172/ijhpm.2023.6901
PMCID: PMC10125170     PMID: 37579467    
Article
PDF
XML
Cited By:
Commentary

18. The Fentanyl System Shock – Are There Lessons to Learn From the COVID-19 System Shock Framework? Comment on “The COVID-19 System Shock Framework: Capturing Health System Innovation During the COVID-19 Pandemic”
Maximilian Meyer* ORCID, Jean N. Westenberg ORCID, R. Michael Krausz ORCID
Int J Health Policy Manag. 2023;12: 7409 | Published on: 2023 Mar 05. doi: 10.34172/ijhpm.2023.7409
PMCID: PMC10461848     PMID: 37579419    
Article
PDF
XML
Cited By:
Original Article

19. Commercializing Personal Health Information: A Critical Qualitative Content Analysis of Documents Describing Proprietary Primary Care Databases in Canada
Sheryl Spithoff* ORCID, Quinn Grundy ORCID
Int J Health Policy Manag. 2023;12: 6938 | Published on: 2023 May 02. doi: 10.34172/ijhpm.2023.6938
PMCID: PMC10461871     PMID: 37579404    
Article
PDF
XML
Cited By:
Original Article

20. Scaling-Up eConsult: Promising Strategies to Address Enabling Factors in Four Jurisdictions in Canada
Mylaine Breton* ORCID, Catherine Lamoureux-Lamarche, Mélanie Ann Smithman, Erin Keely, Maxine Dumas Pilon, Alexander Singer, Gerard Farrell, Paula Louise Bush, Catherine Hudon, Lynn Cooper, Véronique Nabelsi, Élizabeth Côté-Boileau ORCID, Justin Gagnon, Isabelle Gaboury, Carolyn Steele Gray ORCID, Marie-Pierre Gagnon ORCID, Regina Visca, Clare Liddy
Int J Health Policy Manag. 2023;12: 7203 | Published on: 2023 Sep 05. doi: 10.34172/ijhpm.2023.7203
PMCID: PMC10590220     PMID: 38618827    
Article
PDF
XML
Cited By:
Original Article

21. Delivery and Prioritization of Surgical Care in Canada During COVID-19: An Environmental Scan
Seremi Ibadin, Mary Brindle, Tracy Wasylak, Jill Robert, Stacey Litvinchuk, Khara M. Sauro* ORCID
Int J Health Policy Manag. 2023;12: 8007 | Published on: 2023 Dec 10. doi: 10.34172/ijhpm.2023.8007
PMCID: PMC10843432     PMID: 38618771    
Article
PDF
Suppl 1
Suppl 2
Suppl 3
XML
Cited By:
Short Communication

22. Phase IV Drug Trials With a Canadian Site: A Comparison of Industry-Funded and Non-Industry-Funded Trials
Joel Lexchin* ORCID, Blue Miaoran Dong ORCID, Aravind Ramanathan, Marc-André Gagnon ORCID
Int J Health Policy Manag. 2024;13: 8239 | Published on: 2024 Apr 08. doi: 10.34172/ijhpm.2024.8239
Article
PDF
Suppl 1
Suppl 2
XML
Cited By: